Join the Rituxan group to help and get support from people like you.
Rituxan News (Page 2)
FDA Medwatch Alert: Rituxan (Rituximab) - Dec 18, 2006
Indication: Treatment of CD20-postive, B-cell, non-Hodgkins lymphoma and for moderately-to-severely-active rheumatoid arthritis when there has been inadequate response to other treatments. [Posted...
FDA Medwatch Alert: Rituxan (rituximab) - Oct 8, 2004
Biogen Idec and Genentech notified healthcare professionals of revisions to the WARNINGS section of the prescribing information due to reports of Hepatitis B virus (HBV) reactivation with fulminant...
Ask a question
To post your own question to this support group, sign in or create an account.
Further information
Related condition support groups
Diffuse Large B-Cell Lymphoma, Chronic Lymphocytic Leukemia (CLL), Follicular Lymphoma, Non-Hodgkin's Lymphoma, Rheumatoid Arthritis